Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Associated Capital Group | AC | Nov 25, 2024 | 36.25 | -0.47 |
Assurant | AIZ | Nov 25, 2024 | 227.44 | +0.57 |
Assured Guaranty | AGO | Nov 25, 2024 | 94.69 | +1.72 |
AST SpaceMobile A | ASTS | Nov 25, 2024 | 24.21 | +0.46 |
Astec Industries | ASTE | Nov 25, 2024 | 38.89 | +1.67 |
Astera Labs | ALAB | Nov 25, 2024 | 107.31 | +4.92 |
Astrana Health | ASTH | Nov 25, 2024 | 42.40 | +0.69 |
AstraZeneca ADR | AZN | Nov 25, 2024 | 66.40 | +1.17 |
Astria Therapeutics | ATXS | Nov 25, 2024 | 10.00 | +3.63 |
Astronics | ATRO | Nov 25, 2024 | 17.61 | +2.26 |
AstroNova | ALOT | Nov 25, 2024 | 14.86 | +0.61 |
Astrotech | ASTC | Nov 25, 2024 | 7.62 | -1.04 |
Asure Software | ASUR | Nov 25, 2024 | 9.77 | +1.24 |
AT&T | T | Nov 25, 2024 | 23.10 | -0.35 |
AT&T A Pref | T-A | Nov 25, 2024 | 21.55 | +0.09 |
AT&T C Pref | T-C | Nov 25, 2024 | 20.34 | +0.10 |
ATA Creativity Global ADR | AACG | Nov 25, 2024 | 1.02 | 0.00 |
Atai Life Sciences BV | ATAI | Nov 25, 2024 | 1.68 | +4.35 |
Atara Biotherapeutics | ATRA | Nov 25, 2024 | 12.12 | +5.67 |
Atea Pharmaceuticals | AVIR | Nov 25, 2024 | 3.40 | +0.89 |
Aterian | ATER | Nov 25, 2024 | 2.62 | +1.55 |
Athena Technology Acquisition II | ATEK | Nov 25, 2024 | 11.72 | -0.26 |
Athene A Pref | ATH-A | Nov 25, 2024 | 25.25 | +0.12 |
Athene B Pref | ATH-B | Nov 25, 2024 | 22.21 | +0.86 |
Athene C Pref | ATH-C | Nov 25, 2024 | 25.28 | +0.04 |
Athene D Pref | ATH-D | Nov 25, 2024 | 19.43 | +1.04 |
Athene Holding | ATH-E | Nov 25, 2024 | 27.10 | +0.44 |
Athira Pharma | ATHA | Nov 25, 2024 | 0.63 | -2.26 |
Ati Physical Therapy A | ATIP | Nov 25, 2024 | 1.76 | -3.30 |
ATIF Holdings | ATIF | Nov 25, 2024 | 0.68 | +5.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.